DBL Pharma ranks second in US market

Staff Correspondent | Published: 00:14, Mar 26,2020


Business conglomerate of Bangladesh DBL Group’s new initiative in the United States, DBL Pharmaceuticals Inc took the second position among 13 companies in the methocarbamol tablet market of the US.

The result was released in a recent report by IQVA, said a release.

The first position was held by Indian company Granules Pharma’s partner company in the US.

DBL Group is investing in pharmaceutical industry along with its export-based RMG and ceramic business.

DBL Pharmaceuticals’ factory in Kashimpur of Gazipur will start producing medicines for Bangladesh market by the end of this year.

More about:

Want stories like this in your inbox?

Sign up to exclusive daily email